Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman wit...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Rodríguez-Lojo, M. Almagro, J. M. Barja, F. Piñeyro, L. Pérez-Varela, J. Del Pozo, M. T. Yebra-Pimentel, E. Fonseca
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2010/230417
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549951930892288
author R. Rodríguez-Lojo
M. Almagro
J. M. Barja
F. Piñeyro
L. Pérez-Varela
J. Del Pozo
M. T. Yebra-Pimentel
E. Fonseca
author_facet R. Rodríguez-Lojo
M. Almagro
J. M. Barja
F. Piñeyro
L. Pérez-Varela
J. Del Pozo
M. T. Yebra-Pimentel
E. Fonseca
author_sort R. Rodríguez-Lojo
collection DOAJ
description Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.
format Article
id doaj-art-94828f4c6d5e424bb0da4da333cf40c6
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-94828f4c6d5e424bb0da4da333cf40c62025-02-03T06:08:11ZengWileyDermatology Research and Practice1687-61051687-61132010-01-01201010.1155/2010/230417230417Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis CR. Rodríguez-Lojo0M. Almagro1J. M. Barja2F. Piñeyro3L. Pérez-Varela4J. Del Pozo5M. T. Yebra-Pimentel6E. Fonseca7Department of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Pathology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainDepartment of Dermatology, Complexo Hospitalario Universitario A Coruña, 15006 A Coruña, SpainInterferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.http://dx.doi.org/10.1155/2010/230417
spellingShingle R. Rodríguez-Lojo
M. Almagro
J. M. Barja
F. Piñeyro
L. Pérez-Varela
J. Del Pozo
M. T. Yebra-Pimentel
E. Fonseca
Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
Dermatology Research and Practice
title Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_full Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_fullStr Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_full_unstemmed Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_short Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_sort subcutaneous sarcoidosis during pegylated interferon alfa and ribavirin treatment for chronic hepatitis c
url http://dx.doi.org/10.1155/2010/230417
work_keys_str_mv AT rrodriguezlojo subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT malmagro subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT jmbarja subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT fpineyro subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT lperezvarela subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT jdelpozo subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT mtyebrapimentel subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT efonseca subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc